TrialPloS one2016

Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients.

Eiichiro Nagata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.